Inflammatory bowel disease therapy: current state-of-the-art

2011 ◽  
pp. 1 ◽  
Author(s):  
Wojciech Blonski ◽  
Anna M Buchner ◽  
Gary R Lichtenstein
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
State Of The Art ◽  
Current State ◽  
Disease Therapy ◽  
Inflammatory Bowel

scholarly journals The current state of the art for biological therapies and new small molecules in inflammatory bowel disease

2018 ◽  
Vol 11 (6) ◽  
pp. 1558-1570 ◽  
Author(s):  
Sudarshan Paramsothy ◽  
Adam K. Rosenstein ◽  
Saurabh Mehandru ◽  
Jean-Frederic Colombel
Keyword(s):  
Inflammatory Bowel Disease ◽  
Small Molecules ◽  
Bowel Disease ◽  
State Of The Art ◽  
Biological Therapies ◽  
Current State ◽  
Inflammatory Bowel

scholarly journals Skin Side Effects of Inflammatory Bowel Disease Therapy

2013 ◽  
Vol 19 (5) ◽  
pp. 1086-1098 ◽  
Author(s):  
Joana Torres ◽  
Sébastien Buche ◽  
Emmanuel Delaporte ◽  
Jean-Frédéric Colombel
Keyword(s):  
Inflammatory Bowel Disease ◽  
Side Effects ◽  
Bowel Disease ◽  
Disease Therapy ◽  
Inflammatory Bowel ◽  
Skin Side Effects

Reactive Oxygen Species Scavenging Hollow MnO2 Nanozymes as Carriers Deliver Budesonide for the Synergistic Inflammatory Bowel Disease Therapy

2021 ◽  
Author(s):  
Huiqiang Qiu ◽  
Hengtai Gong ◽  
Yuheng Bao ◽  
Hong Jiang ◽  
Weijun Tong
Keyword(s):  
Reactive Oxygen Species ◽  
Inflammatory Bowel Disease ◽  
Proinflammatory Cytokines ◽  
Bowel Disease ◽  
Active Drug ◽  
Drug Carrier ◽  
Reactive Oxygen ◽  
Oxygen Species ◽  
Disease Therapy ◽  
Inflammatory Bowel

Inflammatory bowel disease (IBD) is related to excessive reactive oxygen species (ROS) and high expression of proinflammatory cytokines. An enzymatically active drug carrier, which can simultaneously scavenge excessive ROS and...

Sign in / Sign up

Export Citation Format

Share Document